跳至主要内容
临床试验/ISRCTN10483274
ISRCTN10483274已完成不适用

Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in children aged 6 to 35 months in comparison to a commercially available influenza vaccine: an observer-blind, randomised, controlled, safety/immunogenicity study

Berna Biotech Ltd, a Crucell Company (Switzerland)0 个研究点目标入组 1,239 人开始时间: 2009年10月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,239

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Healthy children (male or female) aged 6 to 35 months
  • 2. Written informed consent

排除标准

  • 1. Previous influenza vaccination
  • 2. Serious adverse reaction to any influenza vaccine
  • 3. Medical treatment with immune suppressant or immune modulating drugs
  • 4. Presentation of clinical symptoms of active infection and/or body temperature greater than or equal to 38°C

研究者

发起方
Berna Biotech Ltd, a Crucell Company (Switzerland)

相似试验

Assessment of the immunogenicity and safety of the... | 临床试验